| Literature DB >> 27073747 |
Thomas A Ravenscroft1, Cyril Pottier1, Melissa E Murray1, Matt Baker1, Elizabeth Christopher1, Denise Levitch1, Patricia H Brown1, Warren Barker2, Ranjan Duara2, Maria Greig-Custo2, Ana Betancourt2, Mara English2, Xiaoyan Sun3, Nilüfer Ertekin-Taner4, Neill R Graff-Radford5, Dennis W Dickson1, Rosa Rademakers1.
Abstract
Mutations in the gene encoding the presenilin-1 protein (PSEN1) were first discovered to cause Alzheimer's disease (AD) 20 years ago. Since then more than 200 different pathogenic mutations have been reported, including a p.Gly206Ala founder mutation in the Hispanic population. Here we report mutation analysis of known AD genes in a cohort of 27 early-onset (age of onset ≤65, age of death ≤70) Hispanic patients ascertained in Florida. The PSEN1 p.Gly206Ala mutation was identified in 13 out of 27 patients (48.1%), emphasizing the importance of this specific mutation in the etiology of early-onset AD in this population. One other patient carried the known PSEN1 p.Gly378Val mutation. Genotyping of the PSEN1 p.Gly206Ala and p.Gly378Val mutations in 63 late-onset Hispanic AD patients did not identify additional mutation carriers. All p.Gly206Ala mutation carriers shared rare alleles at two microsatellite markers flanking PSEN1 supporting a common founder. This study confirms the p.Gly206Ala variant as a frequent cause of early onset AD in the Hispanic population and for the first time reports the high frequency of this mutation in Hispanics in Florida.Entities:
Keywords: Alzheimer’s disease; Hispanic; diagnosis; early-onset; founder mutation; presenilin 1
Year: 2016 PMID: 27073747 PMCID: PMC4788736
Source DB: PubMed Journal: Am J Neurodegener Dis ISSN: 2165-591X